Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $336.0100 (-2.23%) ($331.9500 - $346.4300) on Thu. Nov. 3, 2016. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.68% (three month average) | | RSI | 25 | | Latest Price | $336.0100(-2.23%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -1.7% a day on average for past five trading days. | | Weekly Trend | REGN declines -3.5% a week on average for past two weeks. | | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(62%) XLV(50%) XBI(45%) IVW(40%) IWF(40%) | | Factors Impacting REGN price | REGN will decline at least -0.84% in a week (0% probabilities).
VIXM(-9%) TLT(-8%) UUP(-7%) TIP(-3%) SHY(-3%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.84% (StdDev 1.68%) | | Hourly BBV | 0 () | | Intraday Trend | -2.2% | | | | | |
|
| Resistance Level | $364.97 | | 5 Day Moving Average | $345.41(-2.72%) | | 10 Day Moving Average | $354.22(-5.14%) | | 20 Day Moving Average | $364.97(-7.93%) | | To recent high | -23.9% | | To recent low | 0% | | Market Cap | $35.627b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |